Facebook Pixel Code

Lupin Share Price

NSE
BSE
FUT
OPT

Here's the live share price of Lupin along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹2,030.25 Closed
-0.02₹ -0.50
As on Nov 21, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Lupin Price Performance

Today's LowToday's High
₹2,022.85₹2,037.15
₹2,030.25
52 Weeks' Low52 Weeks' High
₹1,795.20₹2,402.90
₹2,030.25
Open Price
₹2,030.00
Prev. Close
₹2,030.75
Volume
5,976

Over the last 5 years, the share price of Lupin has gained 18.09% CAGR. Over the past year, the corresponding return has been -0.64%.

Lupin’s current P/E of 21.44x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.

Lupin Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Lupin
-1.214.473.481.73-0.6441.2218.09
Sun Pharmaceutical Industries
1.335.298.542.780.1221.0728.26
Divi's Laboratories
-2.15-3.365.73-2.746.6324.9412.44
Torrent Pharmaceuticals
-3.762.931.3112.3719.0331.4623.15
Cipla
-1.26-9.10-5.052.053.1911.0315.18
Dr. Reddy's Laboratories
-0.02-3.48-2.501.634.2012.675.21
Zydus Lifesciences
-2.06-7.54-6.253.91-2.0932.5516.40
Mankind Pharma
-1.03-8.30-13.73-11.43-12.1116.369.52
Aurobindo Pharma
-1.209.6516.040.27-1.0737.557.32
Alkem Laboratories
-0.342.795.216.101.8222.7615.61
Abbott India
0.84-2.60-9.63-6.218.5614.5614.16
Biocon
-3.558.3910.8016.3322.6711.60-1.15
Laurus Labs
-2.035.819.8963.7399.8929.0527.51
Glenmark Pharmaceuticals
-2.91-0.72-5.1127.9625.7364.8130.88
GlaxoSmithKline Pharmaceuticals
0.49-9.85-10.44-16.575.0123.9110.28
Ipca Laboratories
-4.3611.545.18-2.79-9.1418.065.44
Anthem Biosciences
-6.44-14.42-24.92-13.04-13.04-4.55-2.76
Ajanta Pharma
-1.631.15-6.54-5.94-15.8826.3719.52
Gland Pharma
-1.05-5.86-6.7915.211.301.83-2.83
J B Chemicals & Pharmaceuticals
-5.312.080.083.390.7318.2329.25

Over the last one year, Lupin has declined 0.64% compared to peers like Sun Pharmaceutical Industries (0.12%), Divi's Laboratories (6.63%), Torrent Pharmaceuticals (19.03%). From a 5 year perspective, Lupin has outperformed peers relative to Sun Pharmaceutical Industries (28.26%) and Divi's Laboratories (12.44%).

Lupin Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Lupin Stock Technicals

Moving Average

DaySMAEMA
52,046.42,033.48
102,015.852,022.39
201,983.352,001.73
501,977.221,979.1
1001,956.011,974.74
2001,984.781,973.31

Lupin Share Holding Pattern

In the latest quarter, Lupin saw a drop in promoter holding to 46.90%, while DII stake increased to 26.56%, FII holding fell to 20.50%, and public shareholding moved down to 6.06% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Lupin Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
57,05,5821.051,120.29
46,15,9802.28906.35
42,85,5611.96841.47
42,00,0000.91824.67
30,83,9917.26605.54
28,23,4020.96554.38
27,35,7822.97537.17
26,87,8871.66527.77
25,52,3821.21501.16
25,20,0271494.81

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Lupin Futures

Price
  (%)
As on Invalid Date IST
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Lupin Options

Price
  (%)
Not traded today
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Lupin Corporate Actions

Date Time
Announcement
Nov 22, 2025, 4:17 AM ISTLupin Ltd. - U.S. FDA Has Conducted An Inspection At Company''s Manufacturing Facility Located At Goa, India.
Nov 15, 2025, 10:23 PM ISTLupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 14, 2025, 12:52 PM ISTLupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 13, 2025, 6:10 AM ISTLupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 13, 2025, 3:54 AM ISTLupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

About Lupin

Lupin Ltd. is a Public Limited Listed company incorporated on 01/03/1983 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24100MH1983PLC029442 and registration number is 029442. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 16967.50 Cr. and Equity Capital is Rs. 91.32 Cr. for the Year ended 31/03/2025.

Management

  • Mrs. Manju D Gupta
    Chairperson
  • Mr. Nilesh D Gupta
    Managing Director
  • Ms. Vinita Gupta
    Director & CEO
  • Mr. Ramesh Swaminathan
    Executive Director & Global CFO
  • Mr. Mark D McDade
    Independent Director
  • Dr. Punita Kumar-Sinha
    Independent Director
  • Mr. Jean-Luc Belingard
    Independent Director
  • Mr. Jeffrey Kindler
    Independent Director
  • Mr. Alfonso Zulueta
    Independent Director
  • Mr. K B S Anand
    Independent Director
  • Mr. Punita Lal
    Independent Director

FAQs on Lupin Share Price

What is the share price of Lupin?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lupin is ₹2,030.25 as on Nov 21, 2025.

What kind of stock is Lupin?

The Lupin is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Lupin?

The market cap of Lupin is ₹92,734.14 Cr as on Nov 21, 2025.

What are today's High and Low prices of Lupin?

Today’s highest and lowest price of Lupin are ₹2,037.15 and ₹2,022.85.

What are the 52 Week High and 52 Week Low of Lupin?

The 52-week high/low is the highest and lowest price at which Lupin stock has traded in the past 52-week or nearly a year. The 52-week high of Lupin is ₹2,402.90 and 52-week low of Lupin is ₹1,795.20 as on Nov 21, 2025.

How has the Lupin performed historically in terms of returns?

The Lupin has shown returns of -0.02% over the past day, 4.47% for the past month, 3.48% over 3 months, -0.64% over 1 year, 41.22% across 3 years, and 18.09% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Lupin?

P/E ratio of and PB ratio of Lupin are 21.44 and 5.39 on Nov 21, 2025. While the company gives a dividend yield of 0.59 per annum.

icon
Market Pulse